This study focuses on patients with Hypertrophic Cardiomyopathy, a condition where the heart muscle becomes abnormally thick, making it harder for the heart to pump blood. The research examines the effects of empagliflozin (Jardiance), a medication taken as film-coated tablets, on the physical capabilities of people with this heart condition.

The purpose of this research is to determine if taking empagliflozin tablets (10 mg daily) for twelve months can improve the ability to exercise in people with Hypertrophic Cardiomyopathy. During the study, participants will be divided into two groups – one group will receive empagliflozin while the other will receive a placebo.

The medication being tested, empagliflozin, is already approved for other medical conditions. The study will last for twelve months, during which participants will need to take one tablet daily. Throughout the study, doctors will monitor how well participants can exercise and how their heart condition responds to the treatment.